Catsci

CatSci Ltd is an award-winning innovation partner dedicated to breaking down the silos in drug development to accelerate the delivery of life-changing medicines to patients in need. The company proudly serves customers across the globe with projects, meeting their needs from candidate selection to product launch and beyond. CatSci offers tailored services including route scouting and selection, initial scale-up and risk management for early development. For later development, CatSci provides process design, assessment and optimisation, scale-up for clinical and commercial manufacture, tech transfer and post-approval improvements. The company possesses a range of critical enabling technologies including catalysis, material science, pre-formulation, analytical development, and HPAPI development. They have recently launched their oligonucleotides capability and, through their partnership with AGC Pharma Chemicals, offer scalable small molecule API manufacturing, from grams to tonnes, with complete accountability of tech transfer. Agile, commercially minded and scientifically led, CatSci leverages its highly qualified technical team and state-of-the-art facilities to empower customers to create affordable, best-in-class therapeutics in a safer, greener and more cost-effective way.

Services include:
- Route scouting and selection
- Initial scale-up
- Risk management for early development
- Process design
- Assessment and optimisation
- Scale-up for clinical and commercial manufacture
- Tech transfer
- Post-approval improvements
- Development of critical enabling technologies in catalysis, material science, pre-formulation, analytical development, and HPAPI development
- Oligonucleotides capability
- Scalable small molecule API manufacturing

CatSci continues to meet the evolving healthcare needs of the world, ensuring quality and innovation in all its services. For more information, please visit catsci.com.